Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Termino C 10616 AB
AB
In liquidation
Org 5569857435
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2014 · 11 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Termino C 10616 AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TN
Torbjörn Nordberg
Liquidator
Liquidator
2020
Former (4)
NJ
Niko Jyri Suominen
Chief Executive Officer
Chief Executive Officer
2020 – 2024
JT
Jorma Tapani Tiili
External Signatory
External Signatory
2020 – 2024
JL
Jenny Louise Gentele
Auditor Substitute
Auditor Substitute
2020 – 2024
AT
Angelika Thor
Audit
Audit
2020 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (3)
NJ
Niko Jyri Suominen
Board of Directors
Board of Directors
2022 – 2024
CP
Caj Patrik Joakim Eurenius
Deputy Board Member
Deputy Board Member
2023 – 2024
AY
Anna Yasmeen Kaiser
Board of Directors
Board of Directors
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Termino C 10616 AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network